Federal Reserve Governor Bowman said she would consider adjusting the Fed's policy outlook if war-driven inflation were to broaden.

At the National Healthcare Security Administration (NHSA)’s request, the NHSA Drug Pricing and Procurement Guidance Center compiled, as of April 1, 2026, a list of more than 200 pharmaceutical companies rated “seriously untrustworthy” or “particularly seriously untrustworthy” in price and procurement. The price‑procurement credit ratings are based primarily on bribery amounts, improper pricing behavior and disruption of centralized procurement order. NHSA thresholds for cumulative bribery: ≥10,000 yuan = untrustworthy; ≥500,000 yuan = seriously untrustworthy; ≥1,000,000 yuan = particularly seriously untrustworthy.

Federal Reserve Governor Bowman said the Fed was correct to keep a dovish tilt in its April 29 policy statement.